{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:19Z","timestamp":1761512659676,"version":"3.44.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ando.2009.02.014","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T06:45:23Z","timestamp":1237445123000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anatomie pathologique des tumeurs corticosurr\u00e9naliennes de l\u2019adulte\u00a0: \u00e9tat des lieux et donn\u00e9es r\u00e9centes"],"prefix":"10.1016","volume":"70","author":[{"given":"F.","family":"Tissier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2009.02.014_bib1","article-title":"Pathology and genetics. Tumors of endocrine organs","author":"DeLellis","year":"2004","journal-title":"World Health Organization Classification of Tumors"},{"key":"10.1016\/j.ando.2009.02.014_bib2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2009.02.014_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jc.2005-1739","article-title":"Emerging treatment strategies for adrenocortical carcinoma: a new hope","volume":"91","author":"Kirschner","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-970411","article-title":"Insights into the molecular biology of adrenocortical tumors","volume":"115","author":"Groussin","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2009.02.014_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0242-6498(05)86166-8","article-title":"Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy","volume":"25","author":"Aubert","year":"2005","journal-title":"Ann Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12022-006-0007-z","article-title":"Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas","volume":"17","author":"Giordano","year":"2006","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2009.02.014_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.5858\/2008-132-1263-LOTAC","article-title":"Lesions of the adrenal cortex","volume":"132","author":"McNicol","year":"2008","journal-title":"Arch Pathol Lab Med"},{"year":"1995","series-title":"Tumors of the adrenal gland and extra-adrenal paraganglia","author":"Lack","key":"10.1016\/j.ando.2009.02.014_bib9"},{"key":"10.1016\/j.ando.2009.02.014_bib10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199011153232007","article-title":"Hormonal evaluation of the patient with an incidentally discovered adrenal mass","volume":"323","author":"Ross","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2009.02.014_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/modpathol.3880638","article-title":"Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases","volume":"15","author":"Hoang","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000478-199805000-00012","article-title":"Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature","volume":"22","author":"Lin","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/01913129109016262","article-title":"Oncocytic adrenal cortical carcinoma","volume":"15","author":"el-Naggar","year":"1991","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.urology.2004.04.023","article-title":"Oncocytic adrenocortical carcinoma","volume":"64","author":"Tanaka","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ando.2009.02.014_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00428-007-0536-y","article-title":"Primary adrenocortical sarcomatoid carcinoma: case report and review of literature","volume":"452","author":"Sturm","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ando.2009.02.014_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3346\/jkms.1997.12.4.374","article-title":"Adrenal carcinosarcoma--a case report","volume":"12","author":"Lee","year":"1997","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ando.2009.02.014_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jso.2930450215","article-title":"Adrenal carcinosarcoma","volume":"45","author":"Decorato","year":"1990","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ando.2009.02.014_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00000478-199206000-00011","article-title":"Adrenal carcinosarcoma presenting in a woman with clinical signs of virilization. A case report with immunohistochemical and ultrastructural findings","volume":"16","author":"Fischler","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib19","first-page":"424","article-title":"Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors","volume":"72","author":"Komminoth","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.ando.2009.02.014_bib20","first-page":"1077","article-title":"Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex","volume":"136","author":"Cote","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jcp.2007.050625","article-title":"Pathological and molecular features of adrenocortical carcinoma: an update","volume":"61","author":"Volante","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0046-8177(92)90235-U","article-title":"Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma","volume":"23","author":"Gaffey","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01605986","article-title":"Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms","volume":"420","author":"Schroder","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.ando.2009.02.014_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5858\/2002-126-0170-AIITDO","article-title":"A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases","volume":"126","author":"Loy","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ando.2009.02.014_bib25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00000478-199808000-00007","article-title":"Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00129039-200312000-00009","article-title":"(A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas","volume":"11","author":"Ghorab","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ando.2009.02.014_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000478-199801000-00007","article-title":"Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.pai.0000146525.72531.19","article-title":"Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique","volume":"13","author":"Pan","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ando.2009.02.014_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.0.1650223","article-title":"Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm","volume":"165","author":"Arola","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1097-0142(19990625)87:3<168::AID-CNCR11>3.0.CO;2-V","article-title":"Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration","volume":"87","author":"Fetsch","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2009.02.014_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00129039-200203000-00012","article-title":"Inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas","volume":"10","author":"Jorda","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ando.2009.02.014_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.pap.0000131822.31576.9d","article-title":"Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma","volume":"11","author":"Varma","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib33","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/2007-131-1648-BPIDIH","article-title":"Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms","volume":"131","author":"Kakar","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ando.2009.02.014_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/1097-0142(19850215)55:4<766::AID-CNCR2820550414>3.0.CO;2-7","article-title":"Morphologic characteristics of benign and malignant adrenocortical tumors","volume":"55","author":"van Slooten","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2009.02.014_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajcp\/72.3.390","article-title":"Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data","volume":"72","author":"Hough","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2559.2007.02747.x","article-title":"The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas","volume":"51","author":"van\u2019t Sant","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.ando.2009.02.014_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1309\/MCGUQ3R4A4WWN3LB","article-title":"Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability","volume":"127","author":"Blanes","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib41","first-page":"306","article-title":"Adrenocortical tumors. I. Prognostic evaluation of a series of 17 cases using the Weiss criteria","volume":"13","author":"Wagner","year":"1993","journal-title":"Ann Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib42","first-page":"6762","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2009.02.014_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02739705","article-title":"Proliferation in adrenocortical tumors: correlation with clinical outcome and p53 Status","volume":"8","author":"McNicol","year":"1997","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib46","first-page":"1165","article-title":"Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms","volume":"11","author":"Nakazumi","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0090-4295(00)00852-9","article-title":"Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors","volume":"57","author":"Terzolo","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ando.2009.02.014_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mce.2005.01.012","article-title":"Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors","volume":"233","author":"Kiiveri","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/07435800009048609","article-title":"p53 and Ki67 in adrenocortical tumors","volume":"26","author":"Arola","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/j.ando.2009.02.014_bib50","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.bjc.6600287","article-title":"Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues","volume":"86","author":"Bernini","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ando.2009.02.014_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/eje.0.1450335","article-title":"Discerning malignancy in adrenocortical tumors: are molecular markers useful?","volume":"145","author":"Wachenfeld","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib52","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MP.0000081730.72305.81","article-title":"Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis","volume":"16","author":"Stojadinovic","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2009.02.014_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/erc.1.01130","article-title":"Adrenocortical cancer: pathophysiology and clinical management","volume":"14","author":"Libe","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2009.02.014_bib55","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-06-2085","article-title":"Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity","volume":"13","author":"Libe","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2009.02.014_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/eje.1.02004","article-title":"Molecular genetics of adrenocortical tumours, from familial to sporadic diseases","volume":"153","author":"Libe","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib57","first-page":"3636","article-title":"p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 \u201chot spot\u201d found in Taiwan","volume":"81","author":"Reincke","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib58","first-page":"483","article-title":"Mutations of the p53 gene in human functional adrenal neoplasms","volume":"78","author":"Lin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2559.2006.02505.x","article-title":"IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours","volume":"49","author":"Schmitt","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ando.2009.02.014_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<146::AID-PATH744>3.0.CO;2-7","article-title":"Expression of p53 in adrenocortical tumours: clinicopathological correlations","volume":"181","author":"McNicol","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.0.1450207","article-title":"Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors","volume":"145","author":"Barzon","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib62","first-page":"2048","article-title":"Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression","volume":"85","author":"Wilkin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib63","first-page":"322","article-title":"High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors","volume":"85","author":"Bourcigaux","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/eje.0.1500809","article-title":"Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors","volume":"150","author":"Tissier","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.02.014_bib65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ando.2009.02.014_bib66","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","article-title":"The Wnt signaling pathway in development and disease","volume":"20","author":"Logan","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.ando.2009.02.014_bib67","first-page":"1","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ando.2009.02.014_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0046-8177(98)90052-1","article-title":"Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features","volume":"29","author":"Wakatsuki","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/gcc.20071","article-title":"Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli","volume":"41","author":"Blaker","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ando.2009.02.014_bib70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis","volume":"162","author":"Giordano","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ando.2009.02.014_bib71","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2009.02.014_bib72","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2008-0631","article-title":"Wnt\/beta-catenin and 3\u2019, 5\u2019-cyclic adenosine 5\u2019-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors","volume":"93","author":"Gaujoux","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.02.014_bib73","first-page":"155","article-title":"Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of 55 cases","volume":"23","author":"Macfarlane","year":"1958","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ando.2009.02.014_bib74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1445-2197.2003.02746.x","article-title":"Clinical and molecular aspects of adrenocortical tumourigenesis","volume":"73","author":"Sidhu","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ando.2009.02.014_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.134.2.181","article-title":"Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection","volume":"134","author":"Harrison","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2009.02.014_bib76","first-page":"1303","article-title":"Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas","volume":"17","author":"Edgren","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ando.2009.02.014_bib77","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426609000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426609000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:43:09Z","timestamp":1757716989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426609000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0003426609000493"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2009.02.014","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anatomie pathologique des tumeurs corticosurr\u00e9naliennes de l\u2019adulte\u00a0: \u00e9tat des lieux et donn\u00e9es r\u00e9centes","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2009.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}